trending Market Intelligence /marketintelligence/en/news-insights/trending/dRdzwOJuGd1uL--_2Ktp3w2 content esgSubNav
In This List

Sanofi launches digitally enabled manufacturing site in Massachusetts

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Sanofi launches digitally enabled manufacturing site in Massachusetts

Paris-based Sanofi established its first digital manufacturing facility for biologics production in Framingham, Mass.

The new facility will manufacture biologics for Sanofi's specialty care segment, the French drugmaker said in an Oct. 15 news release.

The production facility is part of Sanofi's move to focus on biologics-based therapies as the company transforms its research and development pipeline.

Sanofi aims to increase levels of productivity, agility and flexibility using the manufacturing site's advanced technologies, the company added.

The company plans to expand its digital transformation initiative in its facilities in Toronto, as well as in Suzano, Brazil; Waterford, Ireland; Sisteron, France; and Geel, Belgium.